AB
Arkea Bio Corp.
SEC filingOther Technology · Charlestown, MA
Amount raised$7Msold at filing
Total offering$12M$5M still open
Investors in the raise2count reported to the SEC
FiledOct 14, 2025first sale Sep 26, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Frank WootenExecutive Officer, Director
Wayne McNeeDirector
Chris RivestExecutive Officer, Director
Zachariah SerberExecutive Officer, Director
Executive officers, directors and promoters as listed on the Form D.